FREMONT, Calif., April 28, 2016 /PRNewswire/ -- ValGenesis, Inc., the market leader in Enterprise Validation Lifecycle Management Solutions (VLMS) today announced that a prominent world provider of products and services for sufferers of chronic kidney failure has selected ValGenesis Validation Lifecycle management System to manage their corporate validation process. The global medical device manufacturer had been seeking a software solution to manage their validation processes electronically. Upon completion of their evaluation, they determined that ValGenesis VLMS would significantly improve their current validation process in terms of increased efficiency, reduction in validation lifecycle times, improvement in regulatory compliance as well as providing a holistic view of validation projects across multiple global manufacturing sites.
The flexibility of ValGenesis's automated workflow, form designer and process designer platform will make Validation, Risk and Change management processes easier while significantly reducing the time it takes to accomplish these tasks. Furthermore, the flexibility, web services and scalability tools built into the core solution of ValGenesis software will easily integrate with other software applications such as ERP, LIMS, MES, Document Management Systems, Quality Management Systems and Assets Management Systems, etc.
"ValGenesis has proven its value to all types of Life Science companies, as this particular client is a global expert in dialysis products and solutions as well as a renowned provider in the renal patient care services. We at ValGenesis are delighted to partner with a unique global leading device and services provider, opening yet another arena in the Life Science industry," commented Narayan Raj, Vice President of ValGenesis Inc. "ValGenesis is becoming a de-facto standard for global life science companies, as it allows them to manage their validation process electronically, reduce the validation cycle time, enable standardization, and enforce consistency and compliance in the corporate validation process."
ValGenesis, Inc. is the creator of an innovative software platform serving as the foundation for managing compliance-based validation activities in Life Sciences companies. ValGenesis, Inc. provides the first enterprise application to manage the corporate validation lifecycle process. As the only system for managing validation execution and approval 100% electronically, ValGenesis was selected by an industry peer review committee to receive the Parenteral Drug Association (PDA) New Innovative Technology Award. The solution is fully compliant with U.S. FDA 21 CFR Part 11 and Annex 11 requirements. For more information, visit www.valgenesis.com
SOURCE ValGenesis Inc